KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Income from Continuing Operations (2016 - 2025)

Amgen has reported Income from Continuing Operations over the past 17 years, most recently at 1333000000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 1333000000.0 for Q4 2025, up 112.6% from a year ago — trailing twelve months through Dec 2025 was 7711000000.0 (up 88.53% YoY), and the annual figure for FY2025 was 7711000000.0, up 88.53%.
  • Income from Continuing Operations for Q4 2025 was 1333000000.0 at Amgen, down from 3216000000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for AMGN hit a ceiling of 3216000000.0 in Q3 2025 and a floor of 113000000.0 in Q1 2024.
  • Median Income from Continuing Operations over the past 5 years was 1546000000.0 (2022), compared with a mean of 1548150000.0.
  • Biggest five-year swings in Income from Continuing Operations: crashed 103.98% in 2024 and later skyrocketed 1630.97% in 2025.
  • Amgen's Income from Continuing Operations stood at 1899000000.0 in 2021, then fell by 14.9% to 1616000000.0 in 2022, then crashed by 52.54% to 767000000.0 in 2023, then decreased by 18.25% to 627000000.0 in 2024, then skyrocketed by 112.6% to 1333000000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 1333000000.0 (Q4 2025), 3216000000.0 (Q3 2025), and 1432000000.0 (Q2 2025) per Business Quant data.